BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Gábor Lendvai, Tímea Szekerczés, Benedek Gyöngyösi, Krisztina Schlachter, Endre Kontsek, Adrián Pesti, Attila Patonai, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, András Kiss. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular CarcinomaPathology & Oncology Research 2019; 25(3): 1103 doi: 10.1007/s12253-018-0528-z
2
Tímea Szekerczés, Alíz Gógl, Ildikó Illyés, József Mandl, Katalin Borka, András Kiss, Zsuzsa Schaff, Gábor Lendvai, Klára Werling. Autophagy, Mitophagy and MicroRNA Expression in Chronic Hepatitis C and Autoimmune HepatitisPathology & Oncology Research 2020;  doi: 10.1007/s12253-020-00799-y
3
Tünde Halász, Gábor Horváth, Gabriella Pár, Klára Werling, András Kiss, Zsuzsa Schaff, Gábor Lendvai. miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScanWorld Journal of Gastroenterology 2015; 21(25): 7814-7823 doi: 10.3748/wjg.v21.i25.7814
4
Zhichao Liu, Yuping Wang, Jürgen Borlak, Weida Tong. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different gradesScientific Reports 2016; 6(1) doi: 10.1038/srep23709
5
Alina Simerzin, Elina Zorde-Khvalevsky, Mila Rivkin, Revital Adar, Jessica Zucman-Rossi, Gabrielle Couchy, Tania Roskams, Olivier Govaere, Moshe Oren, Hilla Giladi, Eithan Galun. The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryHepatology 2016; 64(5): 1623 doi: 10.1002/hep.28679
6
Barbora Hanousková, Barbora Neprašová, Lenka Skálová, Lenka Maletínská, Kateřina Zemanová, Martin Ambrož, Petra Matoušková. High-fructose drinks affect microRNAs expression differently in lean and obese miceThe Journal of Nutritional Biochemistry 2019; 68: 42 doi: 10.1016/j.jnutbio.2019.03.001
7
Sara R. Selitsky, Timothy A. Dinh, Cynthia L. Toth, C. Lisa Kurtz, Masao Honda, Benjamin R. Struck, Shuichi Kaneko, Kasey C. Vickers, Stanley M. Lemon, Praveen Sethupathy, Mary K. Estes. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis ProgramsmBio 2015; 6(6) doi: 10.1128/mBio.01500-15
8
Zheng Chen, Jing Ye, Usama Ashraf, Yunchuan Li, Siqi Wei, Shengfeng Wan, Ali Zohaib, Yunfeng Song, Huanchun Chen, Shengbo Cao, R. M. Sandri-Goldin. MicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1Journal of Virology 2016; 90(7): 3722 doi: 10.1128/JVI.03242-15
9
Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisJournal of Hepatology 2018; 69(6): 1335 doi: 10.1016/j.jhep.2018.08.008
10
Jie Shan, Li-Qun Che, Xiao-Li Zhang, Ning An, Bo Ren, Jingyuan Wang. Two Co(II) and Cu(II) coordination polymers: crystal structures and treatment effect on fatty liver disease by reducing the content of the triglyceride in the bloodInorganic and Nano-Metal Chemistry 2020; 50(7): 529 doi: 10.1080/24701556.2020.1720730
11
Anastasia Hyrina, Andrea D. Olmstead, Paul Steven, Mel Krajden, Edward Tam, François Jean. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9EBioMedicine 2017; 23: 68 doi: 10.1016/j.ebiom.2017.08.020
12
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
13
Ayano Takeuchi-Yorimoto, Yu Yamaura, Masayuki Kanki, Tetsuya Ide, Ayumi Nakata, Takahisa Noto, Masahiro Matsumoto. MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver diseaseToxicology Letters 2016; 258: 159 doi: 10.1016/j.toxlet.2016.06.012
14
Joel Vega-Badillo. ALTERACIONES EN LA HOMEOSTASIS DEL COLESTEROL HEPÁTICO Y SUS IMPLICACIONES EN LA ESTEATOHEPATITIS NO ALCOHÓLICATIP 2017; 20(1): 50 doi: 10.1016/j.recqb.2016.11.005
15
Jung-Hsien Hung, Chung-Hsien Li, Ching-Hua Yeh, Pin-Cheng Huang, Cheng-Chieh Fang, Yen-Fu Chen, Kuo-Jui Lee, Chih-Hung Chou, Hsin-Yun Cheng, Hsien-Da Huang, Marcelo Chen, Ting-Fen Tsai, Anya Maan-Yuh Lin, Chia-Hung Yen, Ann-Ping Tsou, Yu-Chang Tyan, Yi-Ming Arthur Chen. MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular CarcinomaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30682-5
16
Weiping Chang, Lei Zhang, Yao Xian, Zhaoxiang Yu. MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinomaExperimental and Therapeutic Medicine 2017; 13(5): 2507 doi: 10.3892/etm.2017.4236